NCT02982226Unknown不适用
A Comparative Study of Injectable Human Amniotic Allograft (ReNu™) Versus Corticosteroids for Plantar Fasciitis: A Prospective, Randomized, Blinded Study
适应症
试验速览
- 阶段
- 不适用
- 入组人数
- 150
- 试验地点
- 11
- 主要终点
- Change in AOFAS score from baseline
研究概览
简要总结
The objective of this clinical trial is to evaluate both the safety and efficacy of the ReNu™ injection on pain and inflammation in subjects diagnosed with plantar fasciitis as compared to a Corticosteroid Injection which is considered standard of care.
详细描述
This is a two (2) arm evaluation in 150 subjects with plantar fasciitis. Patients will be treated with ReNu™(study treatment) or Corticosteroids (control).
At each follow-up visit, concomitant medications and adverse events shall be collected from each subject, and each subject shall complete following questionnaires:
- AOFAS Ankle-Hindfoot Score (AOFAS-AHS)
- Visual Analog Score (VAS)
- Single Answer Numeric Evaluation (SANE)
- Subject Satisfaction Score (at the 6 Month Follow Ups ONLY)
The subjects will be assessed at Baseline (pre-injection) using these scales and again at all subsequent study follow-up visits.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- Single (Participant)
入排标准
- 年龄范围
- 18 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Ages 18 to 75 inclusive
- •BMI less than 40
- •Actively practicing a contraception method, abstinent, surgically sterile, or post-menopausal (defined as no menses for a minimum of 12 months)
- •Reporting heel pain of >6 on a verbally administered 1-10 pain scale where 1 is no pain and 10 is extreme pain
- •Diagnosed with plantar fasciitis in either foot
- •Completed a minimum of two months of conservative, non-injection treatment/therapies (i.e., activity modification, icing, NSAIDs, orthotics, physical therapy, etc.)
- •Exclusion Criteria
- •Prior surgery on the affected foot
- •Prior injection treatment for plantar fasciitis within the past 6 months with steroids or tissue engineered materials just in the site seeking treatment
- •Clinical signs and symptoms of infection of foot in question
- •Evidence of significant neurological disease of either foot
- •Non-ambulatory
- •Presence of comorbidities that can be confused with or can exacerbate the condition including, but not limited to the following:
- •Calcaneal stress fracture
- •Nerve entrapment syndrome, such as Baxter's Nerve Entrapment or Tarsal Tunnel Syndrome
- •Plantar Fascial rupture
- •Systemic disorders associated with enthesiopathy, i.e., Gout, Reiter's syndrome, rheumatoid arthritis, etc.
- •Achilles tendonitis
- •Fat Pad Atrophy
- •Fibromyalgia
- •Diabetic Neuropathy
- •Pregnant, pregnant within the past six (6) months, breast feeding and/or desire to become pregnant during the course of the study, as verified by urine pregnancy test within one week prior to injection.
- •Has taken NSAID medication within the past 14 days, or other pain medication in the past day
- •History of more than two (2) weeks treatment with immuno-suppressants, including systemic corticosteroids or cytotoxic chemotherapy within one month prior to initial screening, or has receive such medications during the screening period, or are anticipated to require such medications during the course of the study.
- •Taking any investigational drug(s) or therapeutic device(s) within 30 days preceding screening
- •History of radiation therapy of the affected foot
- •Known history of having Acquired Immunodeficiency Syndrome (AIDS) or HIV
- •Involved in a Worker's Compensation Claim of any kind
- •Unable to understand the objectives of the trial
- •Presence of any condition(s) which, in the opinion of the investigator, would compromise the subject's ability to complete this study
- •Having a known history of poor adherence with medical treatment.
- •Express an unwillingness to receive human allograft tissue
排除标准
- 未提供
结局指标
主要结局
Change in AOFAS score from baseline
时间窗: 6 months
次要结局
- Change in SANE function score from baseline(6 months)
- Change in VAS pain score from baseline(6 months)
- Return to Normal Function between treatment groups(6 months)
研究者
研究点 (11)
Loading locations...
相似试验
已完成
1 期
Safety and Feasibility of Amniotic Fluid as a Treatment for COVID-19 PatientsSARS CoV-2NCT04497389University of Utah47
已完成
不适用
Comparative Study of Amniotic Membrane Injectable in the Treatment of Recalcitrant Plantar FasciitisPlantar FasciitisNCT01659827MiMedx Group, Inc.45
撤回
4 期
A Randomized Comparison of AmnioClear™ Human Allograft Amniotic Membrane vs. Moist Wound Dressing in the Treatment of Diabetic WoundsDiabetic Foot UlcersWound CareNCT02120755Liventa Bioscience
尚未招募
不适用
Evaluation of Outcomes With Umbilical Cord Allograft for Musculoskeletal Conditions Musculoskeletal ConditionsOsteoarthritisTendinitisDegenerative ArthritisLigament InjuryNeuropathyPelvic PainSports InjuryDegenerative Disc DiseaseNCT03390920R3 Stem Cell200
终止
不适用
Human Amniotic Membrane On Venous Leg Ulcers In an Elderly PopulationVenous Leg UlcerNCT06544564BioLab Holdings30